LFGOX
Price
$31.05
Change
-$0.09 (-0.29%)
Updated
Apr 17 closing price
Net Assets
75.21M
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

LFGOX vs VIGRX

Header iconLFGOX vs VIGRX Comparison
Open Charts LFGOX vs VIGRXBanner chart's image
Lord Abbett Focused Growth F3
Price$31.05
Change-$0.09 (-0.29%)
VolumeN/A
Net Assets75.21M
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
LFGOX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LFGOX vs. VIGRX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFGOX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. LFGOX (75.2M). VIGRX pays higher dividends than LFGOX: VIGRX (0.39) vs LFGOX (0.00). LFGOX was incepted earlier than VIGRX: LFGOX (6 years) vs VIGRX (32 years). LFGOX (1.10) is less costly to investors than VIGRX (0.17). LFGOX is a more actively managed with annual turnover of: 122.00 vs. VIGRX (5.00). LFGOX has a lower initial minimum investment than VIGRX: LFGOX (0) vs VIGRX (3000). LFGOX annual gain was more profitable for investors over the last year : 12.30 vs. VIGRX (6.13). VIGRX return over 5 years is better than : 99.42 vs. LFGOX (70.04).
LFGOXVIGRXLFGOX / VIGRX
Total Expense Ratio0.700.17412%
Annual Report Gross Expense Ratio1.100.17647%
Fund Existence6 years32 years-
Gain YTD-16.352-14.236115%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets75.2M261B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year12.306.13201%
Returns for 3 years26.9930.4689%
Returns for 5 years70.0499.4270%
Returns for 10 yearsN/A224.18-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.31
+1.24%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics